title: POI: a score to modulate GH treatment in children with Prader-Willi syndrome.
authors.forename: A
authors.initials: A
authors.lastname: Salvatoni
authors.forename: J
authors.initials: J
authors.lastname: Berini
authors.forename: G
authors.initials: G
authors.lastname: Chiumello
authors.forename: A
authors.initials: A
authors.lastname: Crinò
authors.forename: S
authors.initials: S
authors.lastname: Di Candia
authors.forename: L
authors.initials: L
authors.lastname: Gargantini
authors.forename: G
authors.initials: G
authors.lastname: Grugni
authors.forename: L
authors.initials: L
authors.lastname: Iughetti
authors.forename: A
authors.initials: A
authors.lastname: Luce
authors.forename: G
authors.initials: G
authors.lastname: Musolino
authors.forename: P
authors.initials: P
authors.lastname: Sogno Valin
authors.forename: V
authors.initials: V
authors.lastname: Spica Russotto
authors.forename: G
authors.initials: G
authors.lastname: Trifirò
mesh_terms: D002648:Child; D002675:Child, Preschool; D003645:Death, Sudden; D005260:Female; D019382:Human Growth Hormone / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008297:Male; D017286:Polysomnography; D017410:Practice Guidelines as Topic; D011218:Prader-Willi Syndrome / Q000188:drug therapy* / Q000401:mortality; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012131:Respiratory Insufficiency / Q000139:chemically induced / Q000401:mortality
chemical_list: D011994:Recombinant Proteins; D019382:Human Growth Hormone